arrow
返回期刊详情
T

Therapeutic Advances in Hematology

IF3.1
论文数569
被引数1333
期刊论文 569
发表时间
Real-world acute myeloid leukemia outcomes during a decade of molecular diagnostic expansion and azacitidine plus venetoclax adoption in Thailand: A single-center implementation cohort泰国十年间分子诊断扩展和吉西他滨联合维奈克拉应用期间急性髓系白血病的真实世界结局:一项单中心实施队列研究
delete2026-10-30
delete0
PREAI
deleteThanawat Rattanathammethee; Noppamas Panyasit; Piangrawee Niprapan; Sirichai Srichairatanakool; Teerachat Punnachet; Nonthakorn Hantrakun; Pokpong Piriyakhuntorn; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Adisak Tantiworawit; Lalita Norasetthada; Ekarat Rattarittamrong
delete分享
delete收藏
Establishing consensus-based recommendations on first-line ruxolitinib failure and transition for myelofibrosis in Korea: A modified Delphi study基于共识的关于韩国骨髓纤维化患者初始鲁索利替尼治疗失败及转换治疗的推荐意见制定:一项改良德尔菲研究
delete2026-10-26
delete0
PREAI
deleteSung-Eun Lee; Seug Yun Yoon; Junshik Hong; Seung Hyun Nam; Min Kyoung Kim; Ho Jin Shin; Sung Hwa Bae; Jinny Park; Yeung-Chul Mun; Soo-Mee Bang; Chul Won Choi; Chul Won Jung; Jong Ho Won; Ha-Young Kwon; Chanmee Park; Sung-Yong Kim
delete分享
delete收藏
Biomarkers in hematological malignancies: A narrative review of diagnostic, prognostic, and predictive applications血液系统恶性肿瘤中的生物标志物:诊断、预后和预测应用的一篇叙述性综述
delete2026-10-26
delete0
PREAI
deleteHarshal Chorya; Madhurima Maity; Pratyush Sachdeva; Venkata Balaji Chenna; Tanmayee Mareedu; Prerna Chandra; Falah Fayaz; Salma Younas; Saleh Mohammed; Pooja Gogia Bhasin; Hasibullah Aminpoor
delete分享
delete收藏
Emicizumab long-term outcomes and coagulation biomarkers in mild or moderate hemophilia A without inhibitors (HAVEN 6)艾美珠单抗在无抑制剂的轻度或中度血友病A患者中的长期疗效及凝血生物标志物(HAVEN 6)
delete2026-10-23
delete0
PREAI
deleteCedric Hermans; Víctor Jiménez-Yuste; Giuliana Ventriglia; Anna Kiialainen; Laurent Frenzel; Olivier Catalani; Jerzy Windyga; Johannes Oldenburg; Christophe Schmitt; Amy D. Shapiro; Johnny Mahlangu; Michaela Lehle; Steven W. Pipe
delete分享
delete收藏
Clinical characteristics and outcome of CLL/SLL patients with renal involvement in the era of targeted drugs靶向药物时代伴有肾脏受累的CLL/SLL患者的临床特征及预后
delete2026-10-23
delete0
PREAI
deleteLing Gao; Minjie Yu; Lixia Sheng; Zhen Wang; Bo Zhang; Xiaoqian Liu; Tonglu Qiu; Wei Zhang; Luomengjia Dai; Ziyuan Zhou; Lei Fan; Jianyong Li; Huayuan Zhu
delete分享
delete收藏
Real-life venous thromboembolism risk scores in multiple myeloma receiving daratumumab, lenalidomide, and dexamethasone接受达雷木单抗、来那度胺和地塞米松治疗的多发性骨髓瘤患者现实生活中的静脉血栓栓塞风险评分
delete2026-10-14
delete0
PREAI
deleteCarmine Liberatore; Matteo Candeloro; Francesca Fioritoni; Nicola Potere; Simone Ciavarella; Desiree Tuosto; Stefano Pulini; Ettore Porreca; Marcello Di Nisio; Mauro Di Ianni
delete分享
delete收藏
Real-world effectiveness and usage of rFIXFc prophylaxis in hemophilia B: Final results from the B-MORE study
delete2026-10-08
delete0
PREAI
deleteHeidi Glosli; Mahasen Al Saleh; Beatrice Nolan; David Allsup; Susanna Ranta; Olga Benitez Hidalgo; Eva Bednar; Sabine Lauer; Stefan Lethagen;
delete分享
delete收藏
Real-world effectiveness of pegcetacoplan in individuals with paroxysmal nocturnal haemoglobinuria and suboptimal response to C5 inhibitorspegcetacoplan在阵发性夜间血红蛋白尿症且对C5抑制剂反应不佳的患者中的真实世界有效性
delete2026-10-01
delete0
PREAI
deleteŁukasz Szukalski; Jaroslav Čermák; Lenka Mastíková; Ana Boban; Sławomir Jurek; Patrycja Mensah-Glanowska; Anna Szmigielska-Kapłon; Justyna Kozińska; Karla Rener; Paweł Bernatowicz; Elżbieta Kalicińska; Delia Soare; Andrzej Balcerzak; Horia Bumbea; Marek Hus; Jerzy Windyga; Marta Sobas; Jarosław Czyż
delete分享
delete收藏